FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas

The FOXP1 (forkhead box P1) transcription factor is a marker of poor prognosis in diffuse large B-cell lymphoma (DLBCL). Here microarray analysis of FOXP1-silenced DLBCL cell lines identified differential regulation of immune response signatures and major histocompatibility complex class II (MHC II)...

Podrobná bibliografie
Hlavní autoři:	Brown, P, Wong, K, Felce, S, Lyne, L, Spearman, H, Soilleux, E, Pedersen, L, Møller, M, Green, T, Gascoyne, D, Banham, A
Médium:	Journal article
Jazyk:	English
Vydáno:	Nature Publishing Group 2015

Podobné jednotky

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
Autor: Wong, K, a další
Vydáno: (2016)

The significance of FOXP1 in diffuse large B-cell lymphoma
Autor: Gascoyne, D, a další
Vydáno: (2016)

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
Autor: Wong, K, a další
Vydáno: (2014)

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.
Autor: Wong, K, a další
Vydáno: (2014)

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
Autor: Brown, P, a další
Vydáno: (2016)

The NFIL3 transcription factor is preferentially expressed in BCR-independent mature B-cell malignancy
Autor: Gascoyne, D, a další
Vydáno: (2012)

Vitamin D receptor expression in plasmablastic lymphoma and myeloma cells confers susceptibility to vitamin D
Autor: Gascoyne, D, a další
Vydáno: (2016)

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells
Autor: Philip J. Brown, a další
Vydáno: (2016-07-01)

Is FOXP3 expressed in cutaneous T-cell lymphomas?
Autor: Banham, A, a další
Vydáno: (2008)

FOXP3 expression in B and T cell lymphomas.
Autor: Roncador, G, a další
Vydáno: (2005)

The forkhead transcription factor FOXP2 is required for regulation of p21WAF1/CIP1 in 143B osteosarcoma cell growth arrest
Autor: Gascoyne, DM, a další
Vydáno: (2015)

Identification of FOXP1 Transcriptional Targets in Diffuse Large B Cell Lymphoma
Autor: Camilleri, E, a další
Vydáno: (2012)

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
Autor: Banham, A, a další
Vydáno: (2005)

TRPM4 expression is associated with activated B-cell subtype and poor survival in diffuse large B-cell lymphoma
Autor: Loo, S, a další
Vydáno: (2017)

The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21WAF1/CIP1 in 143B Osteosarcoma Cell Growth Arrest.
Autor: Duncan M Gascoyne, a další
Vydáno: (2015-01-01)

CRISPR/Cas9-mediated Foxp1 silencing restores immune surveillance in an immunocompetent A20 lymphoma model
Autor: Felce, SL, a další
Vydáno: (2020)

Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species.
Autor: Banham, A, a další
Vydáno: (2009)

Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement
Autor: Sharon L. Barrans, a další
Vydáno: (2007-06-01)

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
Autor: Barrans, S, a další
Vydáno: (2004)

The architectural pattern of FOXP3(+) T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
Autor: Farinha, P, a další
Vydáno: (2006)

The architectural pattern of FOXP3*T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
Autor: Farinha, P, a další
Vydáno: (2006)

Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement.
Autor: Barrans, S, a další
Vydáno: (2007)

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
Autor: Nyman, H, a další
Vydáno: (2009)

BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas
Autor: Nyman, H, a další
Vydáno: (2008)

Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation.
Autor: Haralambieva, E, a další
Vydáno: (2006)

Strong expression of FOXP1 predicts for poor prognosis within the non-germinal centre subgroup of diffuse large B cell lymphoma
Autor: Barrans, S, a další
Vydáno: (2005)

Tumor-associated macrophages in diffuse large B-cell lymphoma
Autor: Robert Kridel, a další
Vydáno: (2015-02-01)

t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.
Autor: Fenton, J, a další
Vydáno: (2006)

The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells
Autor: Martine van Keimpema, a další
Vydáno: (2017-03-01)

Development of transplantable B-cell lymphomas in the MHC-defined miniature swine model
Autor: Alec R. Andrews, a další
Vydáno: (2019-09-01)

FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.
Autor: Roncador, G, a další
Vydáno: (2005)

Serologic detection of diffuse large B-cell lymphoma-associated antigens.
Autor: Liggins, A, a další
Vydáno: (2004)

Diffuse b-cell lymphoma
Autor: C Grosu, a další
Vydáno: (2011-03-01)

Pathway activation patterns in diffuse large B-cell lymphomas.
Autor: Bentink, S, a další
Vydáno: (2008)

The FOXP3 transcription factor as a regulatory T-cell marker
Autor: Banham, A
Vydáno: (2008)

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.
Autor: Nyman, H, a další
Vydáno: (2009)

FOXP3+ regulatory T cells as biomarkers in human malignancies.
Autor: Bignone, P, a další
Vydáno: (2008)

Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression
Autor: Anja Mottok, a další
Vydáno: (2015-11-01)

Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.
Autor: Brown, P, a další
Vydáno: (2008)

Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma.
Autor: Weniger, M, a další
Vydáno: (2006)